Serum amyloid P down-regulates CCL-1 expression, and inhibits Ras/MAPK signaling and development of breast cancer | |
Ding, Shuhong; Li, Hongzhi; Li, Xiaohui; Wang, Wenwen; Du, Xiuling; Dong, Guoying; Zhang, Ping | |
刊名 | TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH |
2017 | |
卷号 | 16期号:9页码:2089-2095 |
关键词 | Serum amyloid component P (SAP) chemokine (CC motif) ligand 1 (CCL-1) Breast cancer NF-kappa B Ras/MAPK signaling pathway |
DOI | 10.4314/tjpr.v16i9.7 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4589302 |
专题 | 山东大学 |
作者单位 | 1.Shandong Univ, Hosp 2, Dept Breast Dis, Jinan, Shandong, Peoples R China. 2.[L |
推荐引用方式 GB/T 7714 | Ding, Shuhong,Li, Hongzhi,Li, Xiaohui,et al. Serum amyloid P down-regulates CCL-1 expression, and inhibits Ras/MAPK signaling and development of breast cancer[J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH,2017,16(9):2089-2095. |
APA | Ding, Shuhong.,Li, Hongzhi.,Li, Xiaohui.,Wang, Wenwen.,Du, Xiuling.,...&Zhang, Ping.(2017).Serum amyloid P down-regulates CCL-1 expression, and inhibits Ras/MAPK signaling and development of breast cancer.TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH,16(9),2089-2095. |
MLA | Ding, Shuhong,et al."Serum amyloid P down-regulates CCL-1 expression, and inhibits Ras/MAPK signaling and development of breast cancer".TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH 16.9(2017):2089-2095. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论